
Releases
Alzheimer's Association Launches $100 Million PROTECT-Cog Trial
A new $100 million global clinical trial is set to determine if pairing intensive lifestyle interventions with metabolism-targeting drugs can stall cognitive decline. Announced at the Alzheimer's Association International Conference in London, the PROTECT-Cog study seeks to build on earlier research by testing the combined effects of biology and behavior.























